Connect with us
Ship2B launched its first investment vehicle in 2016, with €4.5 million, investing in 23 companies of which they have already divested from three companies. In 2020, the...
Gilead Sciences had $6.4 billion in revenue in the first quarter of 2023, a 4% year-over-year decrease from the same period a year earlier. The company...
The objective of this first round of investment is to complete the development of the platform through which the company will provide services, with special attention...
AAVantgarde has two proprietary platforms for AAV-based large gene delivery: one that takes advantage of DNA recombination, called dual hybrid, and one of protein trans-splicing, called...
Better works with healthcare professionals to determine which type of medications are best for patients, after having analyzed and parameterized their data. The company's platform, Better Meds, provides...
This year, the group plans to start marketing in Europe and sell 20,000 units of its devices, which will increase to 50,000 units in 2024. After...
To date, Ephion has agreements with five hospitals for the implementation of its Ephion Mobility technology in neuromuscular diseases: the Sant Joan de Deu Hospital, the...
Docline maintains an agreement with Mapfre, with whom it offers digital health programs to the company's policyholders; with the Ballesol retirement home company, to whose patients it...
Sicit specializes in the transformation of leather by-products into biostimulants for agriculture and retardants for the gypsum industry. The company offers a strategically important service for...
Looking ahead to 2024, the group plans to reach break-even, when the European Medicines Agency approves its drug against glioblastoma, an aggressive type of cancer that...
 |
|
 |  |
 |
|